Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence

Sandeep Kumar, Sergey Ivanov, Alexey Lagunin, Rajesh Kumar Goel. Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence. Comp. in Bio. and Med., 108:305-316, 2019. [doi]

@article{KumarILG19,
  title = {Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence},
  author = {Sandeep Kumar and Sergey Ivanov and Alexey Lagunin and Rajesh Kumar Goel},
  year = {2019},
  doi = {10.1016/j.compbiomed.2019.03.002},
  url = {https://doi.org/10.1016/j.compbiomed.2019.03.002},
  researchr = {https://researchr.org/publication/KumarILG19},
  cites = {0},
  citedby = {0},
  journal = {Comp. in Bio. and Med.},
  volume = {108},
  pages = {305-316},
}